Covered recipient · General Payments record
ROBIN JUNE COZINE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024–2025
$1,625.32
- Reported across 18 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $875.11 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $123.92 | 1 |
| Neurocrine BioSciences, Inc. | $116.43 | 1 |
| Amgen Inc. | $115.22 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $105.36 | 1 |
| Insmed, Inc. | $105.30 | 1 |
| Novo Nordisk AS | $103.56 | 1 |
| Acerta Pharma LLC | $95.63 | 1 |
| ABIOMED | $88.53 | 1 |
| ABBVIE INC. | $21.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.16 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203365483 | CMS |
| ABIOMED | $88.53 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174548938 | CMS |
| Amgen Inc. | $115.22 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228793696 | CMS |
| AstraZeneca Pharmaceuticals LP | $95.63 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206823969 | CMS |
| Boston Scientific Corporation | $105.36 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181572821 | CMS |
| Corcept Therapeutics | $123.92 | 12/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214216416 | CMS |
| Insmed, Inc. | $105.30 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186313063 | CMS |
| Neurocrine BioSciences, Inc. | $116.43 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242796036 | CMS |
| Novo Nordisk Inc | $103.56 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188690289 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.